top of page
We Don’t Just Study Proteins
We Design Novel and Valuable Proteins
Byung-Ha Oh
Founder of Therazyne
▸ Professor, KAIST (Endowed Chair Professor in Future Industry Technology)
▸ 30 years of protein structure research: over 4 publications in Nature, Cell, and Science
▸ 7 years of de novo protein design research: 9 publications including Nature
▸ Ph.D. in Biochemistry, University of Wisconsin–Madison
▸ Professor, Department of Biological Sciences, POSTECH (1994–2009)
▸ Professor, Department of Biological Sciences, KAIST
▸ Recipient of the Asan Award in Basic Medicine (2016)
Sunwoo Hong, Ph.D.
COO
-Ph.D. in Chemisty from POSTECH
-Led R&D to a successful KOSDAQ IPO
-CEO, mCureX Therapeutics
-VP, Head of R&D Center, OliX Pharmaceuticals
BO-Seong Jeong, Ph.D.
Head of R&D Center
-Ph.D. in Biological sciences, KAIST, Korea
-Design of broad-spectrum coronavirus
antibodies and TCR-like antibodies
Scientific Advisory Board
Myung-Ju Ahn, Ph.D.
- Clinician in Hematology-Oncology in
Samsung Medical Center
-2025 Asan Medical Award
Gou Young Koh, Ph.D.
- Endowed Professor, KAIST
-Founding Director, IBS Center
for Vascular Research
Jeon Yeob Jang, Ph.D.
- Clinician in Head & Neck Oncology
in Ajou Unuversity Medical center
Gyun Min Lee, Ph.D.
- Professor, Biological Sciences, KAIST
-Therapeutic protein production &
CHO cell engineering
bottom of page